RN7SL166P (Gene)

Description:RNA, 7SL, cytoplasmic 166, pseudogene

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View RN7SL166P's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with RN7SL166P.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using RN7SL166P.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for RN7SL166P.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with RN7SL166P.

Results found

Linked to

	Label	Description
	GSE192750 adipose overexpression Grunt Fin PNMR OE 1 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 6 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE209582 fluorouracil 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE192750 adipose overexpression Grunt Fin PNMR OE 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE152246 dihydrotestosterone 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE209582 fluorouracil 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182670 ID3 ID ID1 ID4 ID2 overexpression U-87MG Uppsala RNA Messenger 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE183535 MYC inhibition HeLa 5 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 14 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE192750 adipose overexpression Grunt Fin PNMR OE 1 v 9 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE252944 AKT inhibition 3 v 6 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE239844 crizotinib 6 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE209582 fluorouracil 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE192750 adipose overexpression Grunt Fin PNMR OE 5 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE152246 dihydrotestosterone 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE209582 fluorouracil 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE182670 ID3 ID ID1 ID4 ID2 overexpression U-87MG Uppsala RNA Messenger 1 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE183535 MYC inhibition HeLa 5 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE233679 nicotinamide 14 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.